Q6N089 (Q6N089_HUMAN) Homo sapiens (Human)
Ig-like domain-containing protein UniProtKBInterProInteractive Modelling
472 aa; Sequence (Fasta)
No models have been built for this target sequence.
Available Structures
19 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human monoclonal antibody H3v-47 in complex with influenza virus hemagglutinin… |
Heteromer I0AXC3; Q8TCD0; | 6×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; 3×ZN; | ||||
| Assess | ||||||
| VRC03 and 10-1074 Bound BG505 F14 HIV-1 SOSIP Envelope Trimer Structure |
Heteromer P0DOX5; Q2N0S6; Q2N0S7; Q6P5S8; Q8N5F4; | 27×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; | ||||
| Assess | ||||||
| Crystal structure of Fab fragment of anti-CD22 Epratuzumab |
Heteromer Q8TCD0; | |||||
| Assess | ||||||
| Crystal structure of antibody 27F3 recognizing the HA from A/California/04/2009 (H1N1) influenza vi… |
Heteromer C3W5S1; C5MVT7; Q6P5S8; Q9UL78; | |||||
| Assess | ||||||
| RSV prefusion F bound to RSD5 Fab |
Heteromer P03420; Q8N355; | 13×SO4; 2×NAG; | ||||
| Assess | ||||||
| Crystal Structure of the Human Fab VRC38.01, an HIV-1 V1V2-Directed Neutralizing Antibody Isolated … |
Heteromer P01834; | |||||
| Assess | ||||||
| Crystal structure of HIV-1 broadly neutralizing antibody PGT152 |
Heteromer Q8TCD0; | |||||
| Assess | ||||||
| Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (14:0) |
Heteromer P01834; | 1×NKN; | ||||
| Assess | ||||||
| Crystal structure of the humanized apo LT3015 anti-lysophosphatidic acid antibody Fab fragment |
Heteromer P01834; | 2×SO4; 1×PGE; | ||||
| Assess | ||||||
| Crystal structure of the non-neutralizing HIV antibody 13H11 Fab fragment |
Heteromer Q8TCD0; | 4×SO4; 3×EDO; 1×CL; | ||||
| Assess | ||||||
| Crystal structure of the LT3015 antibody Fab fragment in complex with lysophosphatidic acid (18:2) |
Heteromer P01834; | 1×18L; | ||||
| Assess | ||||||
| Crystal structure of catalytic elimination antibody 34E4, triclinic crystal form |
Heteromer Q8TCD0; | 3×CD; | ||||
| Assess | ||||||
| Crystal structure of catalytic elimination antibody 34E4, orthorhombic crystal form |
Heteromer Q8TCD0; | 1×GOL; 1×SO4; | ||||
| Assess | ||||||
| Crystal structure analysis of Fab 2G12 in complex with peptide 2G12.1 |
Heteromer | |||||
| Assess | ||||||
| Human antibody H2897 in complex with influenza hemagglutinin H1 Solomon Islands/03/2006 |
Heteromer A7UPX0; Q6PIL8; | 6×NAG; 3×NAG; 15×NAG; | ||||
| Assess | ||||||
| MACV GP1 CR1-07 Fab complex |
Heteromer Q0KKI6; Q8AZ57; | 1×NAG; | ||||
| Assess | ||||||
| Crystal structure of RV144-elicited antibody CH59 in complex with V2 peptide |
Heteromer G9HS63; Q8N5F4; | 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of human monoclonal antibody H3v-47 |
Heteromer Q8TCD0; | |||||
| Assess | ||||||
| Crystal Structure of the Broadly Neutralizing Anti-HIV Fab F105 |
Heteromer Q6PIL8; | |||||
| Assess | ||||||